Thursday, August 16, 2012
Publication and contact
Mouse models of human CC chemokine receptor 9 (CCR9; CDw199)-expressing
Mouse models based on
CCR9-expressing human colorectal cancer cell lines could help identify new
therapies to treat the disease. In colorectal cancer tumors from patients,
CCR9 levels were upregulated in primary tumors and downregulated in
metastatic tumors. In mice, cell lines derived from the
CCR9-expressing primary colorectal cancer tumors produced a larger number of
gastrointestinal tumors than cell lines derived from the metastatic tumors.
In mice receiving the CCR9-expressing cells, small hairpin RNA against CCR9 decreased tumor formation in the gastrointestinal
tract but also increased tumor formation outside of it compared with
scrambled control shRNA. Ongoing work includes using multiple CCR9-expressing
colorectal cancer cell lines in xenograft mouse models to identify inhibitors
of colorectal cancer metastasis.
SciBX 5(32); doi:10.1038/scibx.2012.852
Published online Aug. 16, 2012
Patent application filed
covering the CCR9-expressing colorectal cancer cell lines; available for
Chen, H.J. et al. J. Clin. Invest.; published online Aug. 6, 2012;
Contact: Steven Lipkin, Weill Cornell Medical College, New
All contents Copyright © 1993-2017 BioCentury Publications, Inc. ALL RIGHTS RESERVED. All use of this Web Site and its contents is governed by the BioCentury User Agreement
. The contents of this Web Site are protected under U.S. and foreign copyright and intellectual property laws, and no part of this Web Site or its contents may be photocopied, reproduced or retransmitted in any form without the written consent of BioCentury, which may be requested from Reprints/Permissions
. BioCentury®; The Bernstein Report on BioBusiness™; The BioCentury 100™; The Clear Route to ROI™; Because Real Intelligence is Hard to Find™; BCIQ™; and BioPharma's Knowledge Center™; are trademarks of BioCentury Publications, Inc., P.O. Box 1246, San Carlos, CA 94070. SciBX® and SciBX: Science-Business eXchange® are trademarks of Nature America, Inc. that are jointly used by BioCentury Publications, Inc. and Nature America, Inc.
Thanks for purchasing this article.
Please bookmark this url for future reference.
We have also sent you a confirming e-mail with a receipt and this same url for your
close [ X ]